John Rossi
Company: CERo Therapeutics
Job title: Senior Vice President Research CERo Research, Head of Translational Medicine
Seminars:
Introducing Chimeric Engulfment Receptors CERs: Combining Classic CAR-T with Small Molecule Therapy to Improve Tumor Cell Clearance 11:30 am
Characterizing CER T cells to enhance inducible target specific cellular damage, uptake and display of tumor antigens for removal of diseased cells Discussing how this novel MOA may lead to a more durable response Presenting non-clinical MOA data and future directionsRead more
day: Day Two
Chair’s Opening Remarks 9:15 am
day: Day Two